In recent years, regenerative techniques have been increasingly studied and used to treat osteochondral lesions of the talus. In particular, several studies have focused their attention on mesenchymal stem cells derived from adipose tissue. Adipose-derived stem cells (ADSCs) exhibit morphological characteristics and properties similar to other mesenchymal cells, and are able to differentiate into several cellular lines. Moreover, these cells are also widely available in the subcutaneous tissue, representing 10 -30% of the normal body weight, with a concentration of 5,000 cells per gram of tissue.
Introduction
Arthroscopy is the gold standard for the treatment of osteochondral lesions of the talus (OLTs) with the aim of pain relief, restoring functionality, and improving quality of life, especially in young and active patients.
Currently, arthroscopic techniques can be classified in three ways. The reparative technique stimulates cells derived from bone marrow through a debridement and microperforations at the level of lesion. The reconstructive technique replaces the lesion using an autologous or heterologous ostechondral graft. The regenerative technique exploits the ability of multipotent cells to differentiate and replicate to reconstruct the damaged tissue 1, 2, 3, 4, 5, 6 .
In recent years , regenerative techniques have been the subject of numerous in vitro and in vivo studies for the treatment of OLTs, and particularly mesenchymal stem cells derived from adipose tissue (ADSCs) 7, 8, 9 . These mesenchymal stem cells exhibit morphological and functional characteristics similar to other multipotent cells, isolated from other tissues; they also have the ability to differentiate into several and different cellular lines both in vitro and in vivo 10, 11, 12, 13 . The focus on research regarding these cells is mainly due to their localization, in fact they represent from 10% to 30% of normal body weight with a concentration of 5,000 cells per gram of tissue 13, 14 . On the other hand, a factor that limits the use of these cells is related to their handling during laboratory procedures. The lipoaspirate containing aggregates of adipocytes, collagen fibers, and normal vascular components is enzymatically processed with collagen A type I, and subjected to hemolysis before culture. The aim here is to describe the protocol for the treatment of osteochondral lesions of the talus using microfractured and purified adipose tissue.
1. Harvesting and processing of the adipose tissue 1. Prepare Klein solution: 1 L of 9 g/L saline, 50 mL of 1% lidocaine, 1 mL of 1:1000 epinephrine, 10 mL of 8.4% sodium bicarbonate, and 0.1 mL of 10 mg/mL of triamcinolone acetonide. 2. Create two para-umbilical incisions of about 0.5 cm with a scalpel blade. Inject approximately 300 mL of Klein solution into the subcutaneous fat tissue of the abdomen through the incisions using 60 mL syringes with a 18G needle (Figure 1 ). 3. Harvest 40 -45 mL of ADSCs using a 13G blunt cannula attached to a 20-mL syringe and introduced into the processing kit (Figure 2) .
Typically, perform the harvesting in the peri-umbilical area. 4. Insert 100 -130 mL of lipoaspirate in the closed system. Push the lipoaspirate into the device through a large filter to obtain a first cluster reduction; at the same time, a corresponding quantity of saline solution exits toward the wasting bag. A key role is played by stainless steel marbles to obtain a temporary emulsion between oil, blood, and saline. Remove oil residues and contaminated blood by a gravity counter-flow of saline solution. 5. After this washing step (the flowing solution appears clear and the lipoaspirate yellow), stop the saline flux and reverse the device (gray cap up), leading to the second adipose cluster reduction. Obtain the reduction by pushing the floating adipose clusters through the second cutting hexagonal filter, pushing fluid from below with a 10-mL syringe. Collect the final product into a 10-mL syringe connected to the upper opening of the device. NOTE: The processing kit for fat tissue improves standard lipofilling technique: in fact, the system consists of a closed, full-immersion, low-pressure cylindrical system, in order to obtain a fluid and uniform product containing a great number of pericytes. This procedure allows the processing of adipose cells exclusively via mild mechanical forces, and preserving the integrity of the stromal vascular niche. The process is the least traumatic possible, and makes the final product available in a short time (15 -20 min), without enzymatic treatments or expansion. Undamaged vasculostromal niches help the healing process. 6. Once the ADSCs have been harvested, apply a compression bandage on the abdomen. Mark the following ( Figure 3 ): both malleoli (lateral (LM) and medial (MM)) the anterior joint line (JL), identified with dorsi-and plantar-flexion of the ankle joint the tibialis anterior tendon (TAT), and Achilles tendon the great saphenous vein, which runs just ahead of the medial malleolus the superficial peroneal nerve (SPN) 3. First, perform the anteromedial portal just medial to the tibialis anterior tendon, coinciding with a soft spot. This portal represents the approach portal. In most cases, a depression with the ankle in dorsiflexion is visible and palpable.
1. Cut only the skin with a blade, and then perforate the capsule by blunt dissection. Take care to avoid the saphenous nerve and the great saphenous vein. The saphenous vein is located 9 mm laterally to the portal, while the nerve is about 7.4 mm lateral to the portal. This constitutes one of two primary viewing portals.
4. Check the joint line, place the anterolateral portal, medial to the lateral malleolus, and lateral to the extensor digitorum tendon. NOTE: When performing the anterolateral portal, prevent any injuries to the intermediate dorsal cutaneous nerve (the lateral branch of the superficial peroneal nerve); for this reason, after cutting, the skin must be followed by blunt dissection. 5. Inspect the articular cartilage to assess size and position. Evaluate the condition and the quality of the cartilage with the palpator.
Osteochondral lesions of the talus are usually located either posteromedially or anterolaterally. 1. Perform arthroscopic treatment using wide-angle 2.7-mm arthroscopes with a 30° viewing angle, though some surgeons will use a larger 4 mm arthroscope, and keep the instrument in the anterior recess of the joint. Non-invasive joint distraction techniques and hyper plantar flexion can be used to access most of the talar dome. 2. In case of a posterior lesion, percutaneously place a Hintermann spreader to distract the joint and allow exposure of the lesion.
The Hintermann spreader has an opening lever arm applied on two K-wires previously positioned in the tibia and talar bone medially or laterally, according to the lesion side. In the case of a lateral lesion, take care to insert the proximal K-wire in the tibial bone, avoiding the fibula, to achieve better distraction of the joint.
6. Prepare the lesion with a curette, removing the damaged and unstable cartilage, the calcified layer and necrotic and sclerotic bone in order to create a regular-shaped contained lesion with shouldered borders. For this step, use a standard arthroscopic curette ( Figure  4 ). 7. Stimulate bone marrow stem cells from subchondral bone performing microperforations roundly from the outside to the inside of the lesion. 8. Remove the intra-articular water using the shaver in aspiration and the remaining liquid using a cotton sponge until the joint is completely dry.
3. Adipose-derived stem cell injection 1. Inject 5 -7 mL of adipose-derived stem cells, previously prepared in Step 4.1.3, into the ankle joint using one of the two portals (anteromedial or anterolateral). 2. Release the tourniquet.
Postoperative Care
1. Avoid ankle movements for 15 days, with the operated limb in full discharge. 2. 15 days after surgery, allow active and passive movements of the ankle, until full recovery and range of motion is reached. 3. Allow charge 30 days after surgery.
Clinical and Radiographic Follow-Up
1. Evaluate patients clinically and radiologically at six and twelve months and, thereafter, annually. The follow-up protocol consists of AOFAS ankle and hind-foot scores, VAS pain score, and SF-12 at each end-point 15, 16, 17 . Radiographic examination includes an MRI and CT-scan of the operated ankle.
Representative Results
Between January 2016 and September 2016, four patients underwent arthroscopic treatment of osteochondral lesion of the talus with microfractured and purified adipose tissue. All patients reported clinical improvement six months after surgery. Preliminary clinical results are reported in Table 1 . No complications were reported.
In recent years, the use of ADSCs for the treatment of foot and ankle pathologies has increased. In 2013, Kim et al. 23 treated 65 elderly patients, older than 50 years for symptomatic OLT dividing for the type of treatment: -isolated marrow stimulation -marrow stimulation in association with ADSCs
At final follow-up, patients with a combined treatment showed significant clinical improvement compared to the isolated marrow stimulation treatment. A subsequent study, conducted by the same group 24 , for the treatment of OLT, confirmed how the combined treatment of SVF and marrow stimulation was superior to isolated microfracture. 
Discussion
In recent years, clinical and preclinical trials have focused their attention on the effect of ADSCs to treat different musculoskeletal pathologies. The aim of this article is to describe the protocol for the treatment of osteochondral lesions of the talus using microfractured and purified adipose tissue in association with arthroscopic microperforations. The protocol involves several critical steps with high risks of complications. During fat harvesting, complications can be divided into local or systemic complications.
The most common postoperative complication is contour irregularities, with an incidence of 2.7%. This can be avoided using small cannulas, not performing superficial liposuction, and turning the suction off when exiting incisions. Rarely, skin conditions such as hyperpigmentation, necrosis, and erythema in patients with underlying connective tissue disease can be seen 27, 28 . Seromas are often the result of aggressive liposuction due to the collection of serous fluid in a treated area leading to the formation of a single cavity; this is most common in patients with high BMI 29 .
Infection is a very rare complication (<1%) and this may be because of a combination of sterile technique, small incisions, and the antibacterial effects of lidocaine 30 .
The literature reports subsequent life-threatening complications after liposuction, such as pulmonary embolism, fat embolism, sepsis, necrotizing fasciitis, and perforation of abdominal organs. The most common cause of death is pulmonary thromboembolism. These complications are due to lack of sterility, poor patient compliance, and permissive post-operative discharge 30 . Also during arthroscopy, there are critical steps that can lead to complications: in this protocol, all arthroscopic procedures are performed using an anteromedial and anterolateral portal 31 . The most frequent complication with this approach is a deficit of the superficial peroneal nerve, reported in 1.04% of patients, despite preoperative marking of the nerve and its branches 32, 33 . Furthermore, the risk increases considering variations of this nerve: anatomical studies have demonstrated that 50% of the population present two branches, and these can reach up to 5 branches with an extremely variable width (1 to 13 mm).
The technique described in the protocol combines the effect of the microfracture in association with mesenchymal stem cells harvested from fat tissue. Microperforations stimulate the development of a reparative tissue: drilling the subchondral bone produces bleeding and leakage of mesenchymal cells, to produce fibrocartilage. The success of microfractures is strictly related to the size of the lesion. If lesions are less than 1.5 cm 2 , the neo-formed fibrocartilage tissue, although qualitatively different from hyaline cartilage and with lower mechanical properties, can provide adequate reparation, with resolution of the symptoms in a high percentage of cases 34, 35 . ADSCs may form neo-tissue with a hyaline cartilage phenotype, if cultured in association with different growth factors (TGFb, GH, and FGF-2) and placed in a scaffold of fibrin glue 36 .
The described technique preserves the identity of the pericyte, leaving intact the stromal vascular niche, promoting osteochondral healing in this way. Moreover, ADSCs produce a variety of paracrine bioactive molecules and can activate the physiological healing process. The final product is available in less than 20 min, thanks to the gentle mechanical method. Finally, in accordance with the US Food and Drug Administration, ADSCs are minimally manipulated.
The use of MSCs is constantly increasing, and future research should focus on the use of allogeneic ADSCs as described by Lee 37 . The advantages of an allotransplant would be numerous. First of all, handling and standardization of the product would be easier. Liposuction and processing steps could be eliminated, and a healthy donor could be pre-selected, according to his cytokine and cell marker expression profile, improving the effect of MSCs 38 .
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